Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
NCT04496141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2024-02-28
Summary
Achieved serum samples of persons with or without evidence of COVID-19 infection are tested using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the immunoassays is then assessed by comparing the 2 groups of samples.
Conditions
- Covid19
Interventions
- DIAGNOSTIC_TEST
-
SARS-CoV-2 antibody immunoassays
Different commercial SARS-CoV-2 antibody immunoassays
Sponsors & Collaborators
-
Hong Kong Sanatorium & Hospital
lead INDUSTRY
Principal Investigators
-
Jonpaul Sze Tsing Zee, MBChB · Hong Kong Sanatorium & Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-07-27
- Primary Completion
- 2020-08-31
- Completion
- 2020-08-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
NCT04775069 ·Status: COMPLETED ·Phase: PHASE4
-
National Covid-19 Surveillance Physicians
NCT04459312 ·Status: UNKNOWN
-
Using Mixed-methods Approach to Explore the Long-term Effects of COVID-19
NCT05303103 ·Status: COMPLETED
-
Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs
NCT04563247 ·Status: COMPLETED
-
Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
NCT00688389 ·Status: UNKNOWN
-
Effect of a Third COVID-19 Booster Among Health Care Workers
NCT05373459 ·Status: COMPLETED
-
Serological Surveillance for COVID-19 in Central North Carolina
NCT04490174 ·Status: COMPLETED
-
Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention
NCT04030039 ·Status: UNKNOWN
-
COVID-19 Immunity and Changes Over Time
NCT05271669 ·Status: RECRUITING
-
COVID-19 Vaccines in Patients With Chronic Liver Disease
NCT05017805 ·Status: UNKNOWN ·Phase: NA
-
Antigen-specific Immune Response to Hepatitis B Virus in Utero
NCT00845403 ·Status: UNKNOWN
-
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
NCT00168194 ·Status: COMPLETED
-
Immune Dynamics in the Natural History of Chronic HBV Infection
NCT07137247 ·Status: RECRUITING
-
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836 ·Status: RECRUITING ·Phase: NA
-
Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital
NCT04525911 ·Status: UNKNOWN
-
Evaluation of the Impact of the Anti COVID-19 Vaccination Campaign Addressed to the Employees of an Italian Hospital.
NCT05774418 ·Status: COMPLETED
-
Risk Factors and Characteristics of COVID 19 Infection in Patients With Haematological Diseases
NCT04930731 ·Status: UNKNOWN
-
Liver Injury After COVID-19 Vaccination
NCT05470894 ·Status: COMPLETED
-
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector
NCT04939402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases
NCT05204602 ·Status: UNKNOWN
-
ID HBV Vaccination With Imiquimod in OBI
NCT03307902 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT01107483 ·Status: COMPLETED
-
Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases
NCT05007665 ·Status: UNKNOWN
-
Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers
NCT04424017 ·Status: COMPLETED
-
Investigation of Hepatitis B and Hepatitis C in Taiwan
NCT00946010 ·Status: COMPLETED